The rest period between chemotherapy and immunotherapy influences the efficacy of immune checkpoint inhibitors in lung cancer
Abstract Background The use of immune checkpoint inhibitors (ICIs) as first‐line treatment rather than as second‐line treatment makes a big difference in the drug efficacy and progression‐free survival. However, the mechanism for this is still not clear. This study aimed to analyze the effects of th...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2022-08-01
|
| Col·lecció: | Thoracic Cancer |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1111/1759-7714.14568 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|